Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 3
1955 1
1956 1
1957 1
1960 3
1961 2
1962 4
1963 4
1964 8
1965 4
1966 12
1967 10
1968 17
1969 14
1970 16
1971 12
1972 13
1973 5
1974 13
1975 16
1976 11
1977 26
1978 32
1979 27
1980 23
1981 23
1982 34
1983 33
1984 33
1985 53
1986 46
1987 49
1988 58
1989 61
1990 50
1991 49
1992 71
1993 76
1994 72
1995 56
1996 54
1997 78
1998 70
1999 61
2000 75
2001 65
2002 102
2003 87
2004 95
2005 99
2006 96
2007 92
2008 107
2009 120
2010 130
2011 115
2012 127
2013 112
2014 147
2015 133
2016 123
2017 152
2018 123
2019 124
2020 184
2021 221
2022 240
2023 228
2024 221
2025 178

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,359 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC.
Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I. Yoneshima Y, et al. Among authors: harada t. J Thorac Oncol. 2021 Sep;16(9):1523-1532. doi: 10.1016/j.jtho.2021.03.027. Epub 2021 Apr 27. J Thorac Oncol. 2021. PMID: 33915251 Free article. Clinical Trial.
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.
Otsubo K, Kishimoto J, Ando M, Kenmotsu H, Minegishi Y, Horinouchi H, Kato T, Ichihara E, Kondo M, Atagi S, Tamiya M, Ikeda S, Harada T, Takemoto S, Hayashi H, Nakatomi K, Kimura Y, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakagawa K, Nakanishi Y, Okamoto I. Otsubo K, et al. Among authors: harada t. Eur Respir J. 2022 Dec 15;60(6):2200380. doi: 10.1183/13993003.00380-2022. Print 2022 Dec. Eur Respir J. 2022. PMID: 35361630 Free article. Clinical Trial.
Hypoxia-induced Wnt5a-secreting fibroblasts promote colon cancer progression.
Harada A, Yasumizu Y, Harada T, Fumoto K, Sato A, Maehara N, Sada R, Matsumoto S, Nishina T, Takeda K, Morii E, Kayama H, Kikuchi A. Harada A, et al. Among authors: harada t. Nat Commun. 2025 Apr 17;16(1):3653. doi: 10.1038/s41467-025-58748-9. Nat Commun. 2025. PMID: 40246836 Free PMC article.
Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR.
Miyauchi E, Morita S, Nakamura A, Hosomi Y, Watanabe K, Ikeda S, Seike M, Fujita Y, Minato K, Ko R, Harada T, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Miyauchi E, et al. Among authors: harada t. J Clin Oncol. 2022 Nov 1;40(31):3587-3592. doi: 10.1200/JCO.21.02911. Epub 2022 Aug 12. J Clin Oncol. 2022. PMID: 35960896 Free PMC article. Clinical Trial.
Neutrophils and Asthma.
Yamasaki A, Okazaki R, Harada T. Yamasaki A, et al. Among authors: harada t. Diagnostics (Basel). 2022 May 8;12(5):1175. doi: 10.3390/diagnostics12051175. Diagnostics (Basel). 2022. PMID: 35626330 Free PMC article. Review.
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial.
Kogure Y, Iwasawa S, Saka H, Hamamoto Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Ebi N, Inoue A, Kurata T, Okamoto I, Yamaguchi M, Harada T, Seike M, Ando M, Saito AM, Kubota K, Takenoyama M, Seto T, Yamamoto N, Gemma A. Kogure Y, et al. Among authors: harada t. Lancet Healthy Longev. 2021 Dec;2(12):e791-e800. doi: 10.1016/S2666-7568(21)00255-5. Lancet Healthy Longev. 2021. PMID: 36098037 Free article. Clinical Trial.
Arachidonic acid-derived dihydroxy fatty acids in neonatal cord blood relate symptoms of autism spectrum disorders and social adaptive functioning: Hamamatsu Birth Cohort for Mothers and Children (HBC Study).
Hirai T, Umeda N, Harada T, Okumura A, Nakayasu C, Ohto-Nakanishi T, Tsuchiya KJ, Nishimura T, Matsuzaki H. Hirai T, et al. Among authors: harada t. Psychiatry Clin Neurosci. 2024 Sep;78(9):546-557. doi: 10.1111/pcn.13710. Epub 2024 Jul 23. Psychiatry Clin Neurosci. 2024. PMID: 39041066 Free PMC article.
Empagliflozin Suppresses the Differentiation/Maturation of Human Epicardial Preadipocytes and Improves Paracrine Secretome Profile.
Takano M, Kondo H, Harada T, Takahashi M, Ishii Y, Yamasaki H, Shan T, Akiyoshi K, Shuto T, Teshima Y, Wada T, Yufu K, Sako H, Anai H, Miyamoto S, Takahashi N. Takano M, et al. Among authors: harada t. JACC Basic Transl Sci. 2023 Aug 9;8(9):1081-1097. doi: 10.1016/j.jacbts.2023.05.007. eCollection 2023 Sep. JACC Basic Transl Sci. 2023. PMID: 37791312 Free PMC article.
An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: The BREATH2 score.
Saito Y, Kagiyama N, Harada T, Kaneko T, Kagami K, Dotare T, Yuasa N, Sato E, Sorimachi H, Murata A, Kawagoshi M, Nishiya Y, Yasui A, Okumura Y, Minamino T, Ishii H, Obokata M. Saito Y, et al. Among authors: harada t. J Cardiol. 2025 Sep;86(3):264-271. doi: 10.1016/j.jjcc.2025.03.018. Epub 2025 Apr 3. J Cardiol. 2025. PMID: 40187528 Free article.
4,359 results